AKRO
Price
$48.22
Change
+$0.10 (+0.21%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
3.85B
77 days until earnings call
NAUT
Price
$0.70
Change
-$0.01 (-1.41%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
88.73M
69 days until earnings call
Interact to see
Advertisement

AKRO vs NAUT

Header iconAKRO vs NAUT Comparison
Open Charts AKRO vs NAUTBanner chart's image
Akero Therapeutics
Price$48.22
Change+$0.10 (+0.21%)
Volume$30.46K
Capitalization3.85B
Nautilus Biotechnolgy
Price$0.70
Change-$0.01 (-1.41%)
Volume$2.4K
Capitalization88.73M
AKRO vs NAUT Comparison Chart in %
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. NAUT commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Buy and NAUT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (AKRO: $48.19 vs. NAUT: $0.70)
Brand notoriety: AKRO and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 68% vs. NAUT: 26%
Market capitalization -- AKRO: $3.85B vs. NAUT: $88.73M
AKRO [@Biotechnology] is valued at $3.85B. NAUT’s [@Biotechnology] market capitalization is $88.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, AKRO is a better buy in the long-term than NAUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while NAUT’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 5 bearish.
  • NAUT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than NAUT.

Price Growth

AKRO (@Biotechnology) experienced а +0.50% price change this week, while NAUT (@Biotechnology) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

AKRO is expected to report earnings on Nov 12, 2025.

NAUT is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.85B) has a higher market cap than NAUT($88.7M). AKRO YTD gains are higher at: 72.969 vs. NAUT (-57.976). NAUT has higher annual earnings (EBITDA): -68.6M vs. AKRO (-279.17M). AKRO has more cash in the bank: 742M vs. NAUT (148M). NAUT has less debt than AKRO: NAUT (28.2M) vs AKRO (37.2M). AKRO (0) and NAUT (0) have equivalent revenues.
AKRONAUTAKRO / NAUT
Capitalization3.85B88.7M4,339%
EBITDA-279.17M-68.6M407%
Gain YTD72.969-57.976-126%
P/E RatioN/AN/A-
Revenue00-
Total Cash742M148M501%
Total Debt37.2M28.2M132%
FUNDAMENTALS RATINGS
AKRO vs NAUT: Fundamental Ratings
AKRO
NAUT
OUTLOOK RATING
1..100
1777
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
10
Undervalued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
5088
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (10) in the null industry is in the same range as AKRO (36). This means that NAUT’s stock grew similarly to AKRO’s over the last 12 months.

AKRO's Profit vs Risk Rating (78) in the null industry is in the same range as NAUT (100). This means that AKRO’s stock grew similarly to NAUT’s over the last 12 months.

AKRO's SMR Rating (96) in the null industry is in the same range as NAUT (96). This means that AKRO’s stock grew similarly to NAUT’s over the last 12 months.

AKRO's Price Growth Rating (50) in the null industry is somewhat better than the same rating for NAUT (88). This means that AKRO’s stock grew somewhat faster than NAUT’s over the last 12 months.

AKRO's P/E Growth Rating (100) in the null industry is in the same range as NAUT (100). This means that AKRO’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKRONAUT
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHPAX18.480.04
+0.22%
Diamond Hill Mid Cap Inv
MDRFX22.41N/A
N/A
BlackRock Mid-Cap Value Investor A
HNCJX20.04N/A
N/A
Hartford International Growth I
FRISX96.97N/A
N/A
Franklin Rising Dividends R6
GSUKX21.34N/A
N/A
Goldman Sachs International Eq Inc R6

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+2.32%
ETNB - AKRO
60%
Loosely correlated
+2.86%
SLS - AKRO
40%
Loosely correlated
-4.71%
MDGL - AKRO
37%
Loosely correlated
+3.06%
IDYA - AKRO
36%
Loosely correlated
+0.61%
NAUT - AKRO
35%
Loosely correlated
-1.66%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with AXON. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-1.66%
AXON - NAUT
42%
Loosely correlated
+0.72%
FHTX - NAUT
42%
Loosely correlated
+5.33%
NRIX - NAUT
41%
Loosely correlated
-1.45%
IMNM - NAUT
41%
Loosely correlated
+2.42%
RXRX - NAUT
39%
Loosely correlated
N/A
More